Discover 177 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 177
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Dothan AL, Atlanta GA, Decatur GA, Lawrenceville GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Pensacola FL, Birmingham AL, Atlanta GA,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Mobile AL, Chattanooga TN, Nashville TN, Clermont FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Mobile AL, Birmingham AL, Owensboro KY, Charleston SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Active & Responsive
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
for
Burns, Trauma
Location: Mobile AL
Sponsor: University of South Alabama
Sex: All
Age: 19 - 70
Code: NCT01812941
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
for
Female Contraception
Location: Mobile AL, Covington LA, New Orleans LA, Marrero LA,
Sponsor: Mylan Pharmaceuticals Inc
Sex: Female
Age: 16+
Code: NCT06672016
Phase3, Recruiting
Active & Responsive
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
for
Carcinoma, Non-Small-Cell Lung
Location: Mobile AL, Baton Rouge LA, Orange City FL, Houston TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05609968
Phase3, Recruiting
Active & Responsive
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
for
Tricuspid Valve Disease
Location: Mobile AL, Cincinnati OH, Indianapolis IN, Baltimore MD
Sponsor: CorMatrix Cardiovascular, Inc.
Sex: All
Age: 1 - 70+
Code: NCT02397668
Recruiting
Active & Responsive
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
for
Large B-cell Lymphoma
Location: Mobile AL, Pensacola FL, Baton Rouge LA, Atlanta GA,
Sponsor: Celgene
Sex: All
Age: 18 - 70+
Code: NCT06356129
Phase3, Recruiting
Active & Responsive
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)